Expression and function analysis of CRABP2 and FABP5, and their ratio in esophageal squamous cell carcinoma

QR Code

Expression and function analysis of CRABP2 and FABP5, and their ratio in esophageal squamous cell carcinoma

The purpose of this study was to explore the effect of CRABP2 and FABP5, and their ratio on prognosis in esophageal squamous cell carcinoma.

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Li Mengyan, Li Chao, Lu Pengfei, Wang Bo, Gao Yongmei, Liu Wengying, Shi Yan, Ma Yuqing
Format:	article
Langue:	EN
Publié:	De Gruyter 2021
Sujets:	esophageal squamous cell carcinoma public database immunohistochemistry crabp2 fabp5 Medicine R
Accès en ligne:	https://doaj.org/article/e76e16cbd3a047daad4f7caeddafc088
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
par: Zongdan Jiang, et autres
Publié: (2021)

New Trend of Surgery in Locally Advanced Esophageal Squamous Cell Carcinoma Patients
par: Tatcha Rerkrak, et autres
Publié: (2021)

Cost-Effectiveness Analysis of Camrelizumab Versus Chemotherapy as Second-Line Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma
par: Hongfu Cai, et autres
Publié: (2021)

Death-Associated Protein Kinase is Underexpressed in High-Grade Oral Squamous Cell Carcinoma
par: Meneses,Ismário Silva de, et autres
Publié: (2010)

Correlation of Human Papillomavirus Infection with Esophageal Squamous Cell Carcinoma
par: O Emadian, et autres
Publié: (2011)

A multi‐omics study delineates new molecular features and therapeutic targets for esophageal squamous cell carcinoma
par: Xing Jin, et autres
Publié: (2021)

A Novel Autophagy-Related Long Non-Coding RNA Signature to Predict Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma
par: Shi X, et autres
Publié: (2021)

Immunoexpression of p53 in Oral Squamous Cell Carcinoma and Oral Dysplastic Lesions in Patients with the Habit of Reverse Smoke
par: Álvarez Martínez,Efraín, et autres
Publié: (2013)

p53 Immunoexpression in Oral Squamous Cell Carcinomas from Different Anatomical Sites: A Comparative Study
par: Sá,Cláudia T., et autres
Publié: (2006)

Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma – Mini Review
par: Shi Y, et autres
Publié: (2021)

Dysregulated circular RNAs as novel biomarkers in esophageal squamous cell carcinoma: a meta‐analysis
par: Chengcheng Guo, et autres
Publié: (2021)

Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma
par: Ke Shi, et autres
Publié: (2021)

Crabp1 Modulates HPA Axis Homeostasis and Anxiety-like Behaviors by Altering FKBP5 Expression
par: Yu-Lung Lin, et autres
Publié: (2021)

Relation Between Tumor Budding and Endoscopic Classification, Degree of Malignancy in T1 Stage Esophageal Squamous Cell Carcinoma
par: WANG Kang, et autres
Publié: (2021)

Advances and challenges in the treatment of esophageal cancer
par: Shiming He, et autres
Publié: (2021)

Comparison of Magnifying Endoscopy with Blue Light Imaging and Narrow Band Imaging for Determining the Invasion Depth of Superficial Esophageal Squamous Cell Carcinoma by the Japanese Esophageal Society’s Intrapapillary Capillary Loop Classification
par: Waku Hatta, et autres
Publié: (2021)

Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma
par: Zu-Xuan Chen, et autres
Publié: (2021)

PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis
par: Xinxin Zhu, et autres
Publié: (2021)

E2F transcription factor 1 is involved in the phenotypic modulation of esophageal squamous cell carcinoma cells via microRNA-375
par: Pengfei Li, et autres
Publié: (2021)

Development and Evaluation of Serum CST1 Detection for Early Diagnosis of Esophageal Squamous Cell Carcinoma
par: Wang J, et autres
Publié: (2021)

Epigenetic Regulator KDM4D Restricts Tumorigenesis via Modulating SYVN1/HMGB1 Ubiquitination Axis in Esophageal Squamous Cell Carcinoma
par: Wenjian Yao, et autres
Publié: (2021)

Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report
par: Tian Zeng, et autres
Publié: (2021)

Self-assembled RNA nanocarrier-mediated chemotherapy combined with molecular targeting in the treatment of esophageal squamous cell carcinoma
par: Xiang Li, et autres
Publié: (2021)

Association between Helicobacter Pylori (H. Pylori) Infection and Esophageal Squamus Cell Carcinoma (ESCC)
par: J Shokry-Shirvany, et autres
Publié: (2012)

Clinical analysis of 117 cases with synchronous multiple primary esophageal squamous cell carcinomas
par: Zhiqin Chen, et autres
Publié: (2021)

Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma
par: Jiannan Yao, et autres
Publié: (2021)

3D Organoids: An Untapped Platform for Studying Host–Microbiome Interactions in Esophageal Cancers
par: Samuel Flashner, et autres
Publié: (2021)

A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis
par: Yang Li, et autres
Publié: (2021)

A methyltransferase‐like 14/miR‐99a‐5p/tribble 2 positive feedback circuit promotes cancer stem cell persistence and radioresistance via histone deacetylase 2‐mediated epigenetic modulation in esophageal squamous cell carcinoma
par: Zhenchuan Liu, et autres
Publié: (2021)

Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence
par: Jason Chia‐Hsun Hsieh, et autres
Publié: (2021)

Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study
par: Peng Yang, et autres
Publié: (2021)

Acantholytic Squamous Cell Carcinoma
par: Sandy Maganito, et autres
Publié: (2021)

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial
par: Mitsuro Kanda, et autres
Publié: (2021)

Cost-Effectiveness Analysis of Camrelizumab vs. Placebo Added to Chemotherapy as First-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
par: Qilin Zhang, et autres
Publié: (2021)

Polimorfismo de la proteína ligante de ácidos grasos intestinal (FABP2), obesidad e insulina resistencia
par: Albala B,Cecilia, et autres
Publié: (2006)

Pigmented Squamous Cell Carcinoma: Is the Reported Prevalence Real?
par: Paola Corneli, et autres
Publié: (2019)

MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel
par: Jie Yan, et autres
Publié: (2021)

Extrahepatic biliary obstruction secondary to metastatic esophageal squamous cell carcinoma: An unusual presentation of Courvoisier's law
par: Kafi Atiba, et autres
Publié: (2021)

Loss of P16 in Esophageal Adenocarcinoma Detected by Fluorescence in situ Hybridization and Immunohistochemistry
par: Kotzev A., et autres
Publié: (2017)

Combination of Endoscopic Resection and Radiofrequency Ablation for the Treatment of Esophageal Squamous Cell Neoplasia With Multiple Lugol-Voiding Lesions
par: Zhihao Chen, et autres
Publié: (2021)